Abstract

BackgroundPreoperative chemotherapy (PCT) has been considered an important treatment for advanced gastric cancer (AGC). The tumor regression grade (TRG) system is an effective tool for the assessment of patient responses to PCT. Pathological complete response (TRG = 0) of the primary tumor is an excellent predictor of better prognosis. However, which patients could achieve pathological complete response (TRG = 0) after chemotherapy is still unknown. The study aimed to find predictors of TRG = 0 in AGC.MethodsA total of 304 patients with advanced gastric cancer from July 2009 to November 2018 were enrolled retrospectively. All patients were randomly assigned (2:1) to training and internal validation groups. In addition, 124 AGC patients receiving PCT from December 2018 to June 2020 were included prospectively in the external validation cohort. A prediction model for TRG = 0 was established based on four predictors in the training group and was validated in the internal and external validation groups.ResultsThrough univariate and multivariate analyses, we found that CA199, CA724, tumor differentiation and short axis of the largest regional lymph node (LNmax) were independent predictors of TRG = 0. Based on the four predictors, we established a prediction model for TRG = 0. The AUC values of the prediction model in the training, internal and external validation groups were 0.84, 0.73 and 0.82, respectively.ConclusionsWe found that CA199, CA724, tumor differentiation and LNmax were associated with pathological response in advanced gastric cancer. The prediction model could provide guidance for clinical work.

Highlights

  • Gastric cancer (GC) causes enormous health and economic burdens worldwide

  • Previous studies showed that complete response (TRG = 0) after preoperative chemotherapy (PCT) was a predictor of good prognosis (13–15)

  • Through the Kaplan-Meier (K-M) survival curve, we found that patients with tumor regression grade (TRG) = 0 had significantly better survival than the others (P = 0.0011, Figure 1A)

Read more

Summary

Introduction

Gastric cancer (GC) causes enormous health and economic burdens worldwide. GC is the fifth most common cancer and the third leading cause of cancer-related deaths worldwide (1, 2). Gastric cancer is often either asymptomatic or may cause only nonspecific symptoms in its early stage. Surgery and chemotherapy are the main methods for the treatment of advanced gastric cancer (AGC). The tumor regression grade (TRG) system is an effective histopathological evaluation method for assessing patient response to PCT. There are several TRG systems for the assessment of the tumor pathological response to PCT, including the Mandard, Ninomiya, Becker and Ryan classification systems (16–19). Different people have different TRG grades, and patients with pathological complete response postchemotherapy have a longer survival and better prognosis. Preoperative chemotherapy (PCT) has been considered an important treatment for advanced gastric cancer (AGC). The tumor regression grade (TRG) system is an effective tool for the assessment of patient responses to PCT. Pathological complete response (TRG = 0) of the primary tumor is an excellent predictor of better prognosis.

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call